Ocugen Statistics
Total Valuation
Ocugen has a market cap or net worth of $427.21 million. The enterprise value is $407.66 million.
Market Cap | 427.21M |
Enterprise Value | 407.66M |
Important Dates
The next estimated earnings date is Monday, August 19, 2024, after market close.
Earnings Date | Aug 19, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Ocugen has 257.35 million shares outstanding. The number of shares has increased by 14.06% in one year.
Shares Outstanding | 257.35M |
Shares Change (YoY) | +14.06% |
Shares Change (QoQ) | +0.23% |
Owned by Insiders (%) | 1.58% |
Owned by Institutions (%) | 12.85% |
Float | 253.38M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 15.22 |
PS Ratio | 60.60 |
Forward PS | n/a |
PB Ratio | 14.12 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 57.82 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.87, with a Debt / Equity ratio of 0.23.
Current Ratio | 1.87 |
Quick Ratio | n/a |
Debt / Equity | 0.23 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -117.30% and return on invested capital (ROIC) is -161.74%.
Return on Equity (ROE) | -117.30% |
Return on Assets (ROA) | -83.60% |
Return on Capital (ROIC) | -161.74% |
Revenue Per Employee | $108,462 |
Profits Per Employee | -$900,062 |
Employee Count | 65 |
Asset Turnover | 0.10 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +176.44% in the last 52 weeks. The beta is 3.75, so Ocugen's price volatility has been higher than the market average.
Beta (5Y) | 3.75 |
52-Week Price Change | +176.44% |
50-Day Moving Average | 1.66 |
200-Day Moving Average | 0.99 |
Relative Strength Index (RSI) | 49.40 |
Average Volume (20 Days) | 7,822,472 |
Short Selling Information
The latest short interest is 53.12 million, so 20.64% of the outstanding shares have been sold short.
Short Interest | 53.12M |
Short Previous Month | 49.06M |
Short % of Shares Out | 20.64% |
Short % of Float | 20.97% |
Short Ratio (days to cover) | 7.91 |
Income Statement
In the last 12 months, Ocugen had revenue of $7.05 million and -$58.50 million in losses. Loss per share was -$0.25.
Revenue | 7.05M |
Gross Profit | 7.05M |
Operating Income | -60.00M |
Pretax Income | -58.50M |
Net Income | -58.50M |
EBITDA | -57.25M |
EBIT | -58.50M |
Loss Per Share | -$0.25 |
Balance Sheet
The company has $26.38 million in cash and $6.83 million in debt, giving a net cash position of $19.54 million or $0.08 per share.
Cash & Cash Equivalents | 26.38M |
Total Debt | 6.83M |
Net Cash | 19.54M |
Net Cash Per Share | $0.08 |
Equity (Book Value) | 30.26M |
Book Value Per Share | 0.12 |
Working Capital | 13.95M |
Cash Flow
In the last 12 months, operating cash flow was -$54.41 million and capital expenditures -$11.22 million, giving a free cash flow of -$65.63 million.
Operating Cash Flow | -54.41M |
Capital Expenditures | -11.22M |
Free Cash Flow | -65.63M |
FCF Per Share | -$0.26 |
Margins
Gross margin is 100.00%, with operating and profit margins of -851.01% and -829.84%.
Gross Margin | 100.00% |
Operating Margin | -851.01% |
Pretax Margin | -829.84% |
Profit Margin | -829.84% |
EBITDA Margin | -812.03% |
EBIT Margin | -829.84% |
FCF Margin | -930.85% |
Dividends & Yields
Ocugen does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -14.06% |
Shareholder Yield | -14.06% |
Earnings Yield | -13.69% |
FCF Yield | -15.36% |
Analyst Forecast
The average price target for Ocugen is $4.67, which is 181.33% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $4.67 |
Price Target Difference | 181.33% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | 87.51% |
EPS Growth Forecast (5Y) | -39.89% |
Stock Splits
The last stock split was on September 30, 2019. It was a reverse split with a ratio of 1:60.
Last Split Date | Sep 30, 2019 |
Split Type | Reverse |
Split Ratio | 1:60 |
Scores
Ocugen has an Altman Z-Score of 0.58 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.58 |
Piotroski F-Score | 2 |